amouravfop alfa subcutaneous (IMM0306S)
/ ImmuneOnco Biopharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 04, 2026
ImmuneOnco’s IMM0306S Subcutaneous Formulation for SLE Approved by NMPA; Autoimmune Pipeline Expands
(ImmuneOnco Press Release)
New trial • Systemic Lupus Erythematosus
1 to 1
Of
1
Go to page
1